Skip to content
Screener

Total Revenue at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$4.29B+16.7%
Opus Genetics logo
Opus GeneticsIRD
$2.16M-50.6%
Regenxbio logo
RegenxbioRGNX
$108.02M+406%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$350K-48.3%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$3.78M+25,107%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$20.16M-48.5%

Segments

By product

See full
Related Party License Revenue$204.64M—
Related Party Service Revenue$104.91M+2,742%
License$74.99M—
Service$11.89M—

Other financials

Income statement

See full
Operating income$244.4M+646%
Net income$160.7M+514%
EPS (diluted)$1.71+456%

Balance sheet

See full
Cash & equivalents$143.2M+345%
Total debt$112.4M+39.6%
Total equity-$58.1M-276%
Total assets$396.4M+99.5%

Cash flow

See full
Operating cash flow-$38.5M+12.3%
CapEx$332.0K-73.1%
Free cash flow-$38.9M+14.0%

Valuation

See full
Market cap$1.02B+51.5%
Enterprise value$993.01M+47.1%
P/E40.8×—
P/S2.6×-22.1×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%—
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%—
Debt / equity27.2×+26.1×
Current ratio3.8×+2.9×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: MeiraGTx Holdings plc’s 10-Q, filed August 13, 2026.

Filed
Aug 13, 2026, 8:23 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-095504
Line itemFor the Three-Month Periods Ended June 30, 2026For the Three-Month Periods Ended June 30, 2025For the Six-Month Periods Ended June 30, 2026For the Six-Month Periods Ended June 30, 2025
Service revenue$11,885—$11,885—
Service revenue - related party104,9063,691105,1995,617
License revenue - related party204,643—204,643—
Total revenue321,4343,691321,7275,617
Operating expenses:
Cost of service revenue1,401—1,401—
Cost of service revenue - related party5,7632,6765,9614,054
General and administrative12,01312,31320,94121,677

Item 1. Financial Statements (Unaudited)

FAQ

What is MeiraGTx Holdings plc's total revenue?
MeiraGTx Holdings plc (MGTX) reported total revenue of $321.43M in Q2 2026.
How has MeiraGTx Holdings plc's total revenue changed year-over-year?
MeiraGTx Holdings plc's total revenue increased by 8608.6% year-over-year, from $3.69M to $321.43M.
What is the long-term trend for MeiraGTx Holdings plc's total revenue?
Over 3 years (2021 to 2025), MeiraGTx Holdings plc's total revenue has grown at a 29.2% compound annual growth rate (CAGR), from $37.7M to $81.39M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about MeiraGTx Holdings plc's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude